Trump says new proposal will slash some U.S. drug prices
President Donald Trump said he was “taking aim at the global freeloading that forces American consumers to subsidize lower prices in foreign countries through higher prices in our country.”
Health Care & Insurance
Articles
Trump focusing on drug prices, high among voters’ concerns
President Donald Trump is linking the drug prices Americans complain about to one of his longstanding grievances: foreign countries the president says are taking advantage of U.S. research breakthroughs.
IU Health covets big prize, but neurosurgery practice clings to independence
Indiana University Health Physicians is setting its sights on one of the state’s last independent specialty holdouts, the neurosurgical Goodman Campbell Brain and Spine.
Purdue delays health care changes for employees’ spouses
The plan approved by Purdue trustees on Oct. 12 met widespread opposition from faculty and staff.
Opioid alternative from Lilly, Pfizer shows promise in study
The experimental drug eased arthritis pain in hard-to-treat patients without major safety concerns, a key step in creating a new class of medications that may one day offer an alternative to narcotics.
Medicare Advantage gaining popularity with lower costs, more benefits
Seema Verma, administrator for the Centers for Medicare and Medicaid Services and former health consultant to Mitch Daniels and Mike Pence, visited Indianapolis on Monday to drum up excitement for the program, which now covers about 20 million Americans.
Purdue trims working spouses from health care plan
Purdue University is joining a trend among large employers by limiting health care coverage for working spouses of the school's faculty and staff.
State study panel makes no recommendation on medical marijuana
Indiana lawmakers listened to more than three hours of testimony Thursday afternoon about whether Indiana should allow for medical marijuana usage but did not come to any consensus on the issue.
Novartis needs U.S. security nod for Endocyte under new rules
The Treasury pilot program implements broader powers Congress granted this year to the Committee on Foreign Investment in the U.S., a panel of officials who review foreign takeover of American firms and can recommend that the president block deals that threaten national security.
Endocyte’s $2.1B deal with Novartis comes after years of setbacks
The West Lafayette biotech firm’s stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.
Endocyte acquisition gives Novartis key therapy—at almost 200 times its last price
One year ago, Indiana-based Endocyte Inc. bought the rights to a prostate cancer treatment for $12 million, plus future considerations. On Thursday, Novartis AG agreed to pay almost 200 times that amount to acquire Endocyte and the experimental therapy.
Novartis to acquire West Lafayette-based Endocyte for $2.1B
The deal represents a huge breakthrough for tiny Endocyte, which has about 90 employees in Indiana but has not yet launched a single product.
Indiana agency approves lower workers’ compensation rates
The agency said Indiana workers' compensation rates have been on a downward trend for several years because of fewer worker injuries and growing payrolls.
Firm planning $25M behavioral health hospital in Plainfield
The standalone, two-story facility is expected to offer a wide array of inpatient and outpatient services, including addiction treatment, counseling and psychiatric intensive care.
U.S. wants drug prices in TV ads: ‘Patients deserve to know’
The drug industry's main trade group said drug companies are only willing to disclose the prices on their websites, not in commercials, and they'll start doing that next spring.
Insurer Anthem agrees to pay record $16M for massive data breach
The nation’s second-largest health insurer has agreed to pay the government a record amount to settle potential privacy violations in the biggest known health care hack in U.S. history, officials said Monday.
Elanco shares lowest since IPO after failing to get consensus buy rating
Shares in Elanco Animal Health Inc. slipped as much as 3.3 percent Monday morning after lead managers and other banks involved in its recent initial public offering started coverage on the animal health company.
Supreme Court asked to review abortion law signed by Pence
Indiana is asking the U.S. Supreme Court to hear arguments over a law that bars women from having an abortion based on gender, race or disability.
BioCrossroads forms $9M seed fund for life science startups
The Indiana Seed Fund III is an early-stage fund focused on developing startups in life sciences, health IT and agricultural biosciences.
Deal with national pharmacy spurs tech company’s growth
An Indianapolis-based company has signed a deal with national mail-order pharmacy GoGoMeds that officials project will help double its local workforce—to about 250—within five years.